Homocysteine levels in schizophrenia and affective disorders-focus on cognition

Ahmed A Moustafa1, Doaa H Hewedi2, Abeer M Eissa2

  • 1School of Social Sciences and Psychology and Marcs Institute for Brain and Behaviour, University of Western Sydney Sydney, NSW, Australia.

Insights

High homocysteine (Hcy) levels are linked to psychiatric disorders like schizophrenia. Vitamin B and folic acid supplements may help, but their impact on cognitive function needs further study.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Homocysteine (Hcy) is implicated in cardiovascular diseases and increasingly recognized in psychiatric disorders.
  • Mechanisms linking Hcy to psychiatric conditions include NMDA receptor interaction, oxidative stress, apoptosis, and mitochondrial dysfunction.

Purpose of the Study:

  • To provide an overview of homocysteine metabolism in psychiatric disorders, focusing on cognitive aspects.
  • To highlight the potential role of Hcy in cognitive impairment associated with schizophrenia and affective disorders.
  • To identify future research directions regarding Hcy and cognitive function in psychiatric patients.

Main Methods:

  • Literature review of studies on homocysteine metabolism, psychiatric disorders, and cognitive function.
  • Analysis of the biological mechanisms connecting Hcy to the pathophysiology of schizophrenia and affective disorders.
  • Examination of the effects of vitamin B and folic acid supplementation on Hcy levels and psychiatric symptoms.

Main Results:

  • Elevated Hcy levels are associated with cognitive impairment in schizophrenia and affective disorders.
  • Vitamin B and folic acid supplementation effectively lowers Hcy levels.
  • Current research indicates potential benefits for negative symptoms in schizophrenia but lacks data on cognitive performance.

Conclusions:

  • Homocysteine plays a significant role in the neurobiology of psychiatric disorders, particularly concerning cognitive function.
  • Further research is needed to investigate the impact of vitamin B and folic acid add-on therapies on cognitive performance in patients with schizophrenia and affective disorders.
  • Understanding Hcy metabolism offers potential therapeutic avenues for cognitive deficits in psychiatric conditions.

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
1.1K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
946
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.2K
The Influence of Cognition on Affect01:29

The Influence of Cognition on Affect

Cognition plays a pivotal role in shaping emotional experiences, as demonstrated by Schachter and Singer’s two-factor theory of emotion. According to this model, emotion arises from a combination of physiological arousal and cognitive interpretation. The body’s physiological response to stimuli is ambiguous and only gains emotional significance through cognitive labeling. For instance, an increased heart rate and adrenaline surge while standing near an attractive person may be...
320
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
1.8K